NEW YORK (GenomeWeb News) — Ariadne Genomics said today that it has partnered with the University of Oklahoma to develop a cancer-related pathways collection.
The collection will then become available to Ariadne customers as an add-on to its pathway-analysis product line, according to the company.
The University of Oklahoma has already deployed Ariadne’s Pathway Studio software tool to develop a collection of cancer-related pathways.
Dee Wu, associate professor at the OU Health Sciences Center, said that the university will “perform scientific evaluation of pathway expansion and microarray data analysis algorithms available in Pathway Studio” in order to “build up a collection of cancer-related pathways using its built-in ResNet database and advanced pathway reconstruction and literature mining tools.”
Financial details were not discussed.